Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 10 |
NetGPI | no | yes: 0, no: 10 |
Related structures:
AlphaFold database: E9AIW3
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 159 | 161 | PF00675 | 0.521 |
CLV_NRD_NRD_1 | 212 | 214 | PF00675 | 0.550 |
CLV_NRD_NRD_1 | 245 | 247 | PF00675 | 0.578 |
CLV_NRD_NRD_1 | 262 | 264 | PF00675 | 0.666 |
CLV_NRD_NRD_1 | 287 | 289 | PF00675 | 0.653 |
CLV_NRD_NRD_1 | 90 | 92 | PF00675 | 0.241 |
CLV_PCSK_KEX2_1 | 235 | 237 | PF00082 | 0.442 |
CLV_PCSK_KEX2_1 | 287 | 289 | PF00082 | 0.630 |
CLV_PCSK_KEX2_1 | 62 | 64 | PF00082 | 0.390 |
CLV_PCSK_KEX2_1 | 90 | 92 | PF00082 | 0.241 |
CLV_PCSK_PC1ET2_1 | 235 | 237 | PF00082 | 0.506 |
CLV_PCSK_PC1ET2_1 | 62 | 64 | PF00082 | 0.384 |
CLV_PCSK_PC7_1 | 231 | 237 | PF00082 | 0.461 |
CLV_PCSK_SKI1_1 | 213 | 217 | PF00082 | 0.494 |
CLV_PCSK_SKI1_1 | 287 | 291 | PF00082 | 0.575 |
CLV_PCSK_SKI1_1 | 62 | 66 | PF00082 | 0.382 |
CLV_PCSK_SKI1_1 | 85 | 89 | PF00082 | 0.238 |
DEG_Nend_UBRbox_4 | 1 | 3 | PF02207 | 0.391 |
DOC_CYCLIN_yCln2_LP_2 | 175 | 181 | PF00134 | 0.524 |
DOC_MAPK_gen_1 | 235 | 242 | PF00069 | 0.469 |
DOC_MAPK_gen_1 | 90 | 98 | PF00069 | 0.497 |
DOC_MAPK_MEF2A_6 | 37 | 45 | PF00069 | 0.338 |
DOC_MAPK_RevD_3 | 75 | 91 | PF00069 | 0.441 |
DOC_PP2B_LxvP_1 | 175 | 178 | PF13499 | 0.543 |
DOC_USP7_MATH_1 | 166 | 170 | PF00917 | 0.576 |
DOC_USP7_MATH_1 | 181 | 185 | PF00917 | 0.328 |
DOC_USP7_UBL2_3 | 243 | 247 | PF12436 | 0.454 |
DOC_USP7_UBL2_3 | 95 | 99 | PF12436 | 0.304 |
LIG_14-3-3_CanoR_1 | 115 | 123 | PF00244 | 0.362 |
LIG_14-3-3_CanoR_1 | 203 | 208 | PF00244 | 0.561 |
LIG_14-3-3_CanoR_1 | 246 | 253 | PF00244 | 0.620 |
LIG_BIR_III_4 | 39 | 43 | PF00653 | 0.440 |
LIG_BRCT_BRCA1_1 | 16 | 20 | PF00533 | 0.348 |
LIG_CaM_IQ_9 | 77 | 93 | PF13499 | 0.429 |
LIG_deltaCOP1_diTrp_1 | 152 | 159 | PF00928 | 0.484 |
LIG_FHA_1 | 104 | 110 | PF00498 | 0.442 |
LIG_FHA_1 | 178 | 184 | PF00498 | 0.501 |
LIG_FHA_1 | 274 | 280 | PF00498 | 0.550 |
LIG_FHA_1 | 45 | 51 | PF00498 | 0.460 |
LIG_FHA_2 | 214 | 220 | PF00498 | 0.470 |
LIG_Integrin_RGD_1 | 6 | 8 | PF01839 | 0.373 |
LIG_LIR_Gen_1 | 117 | 125 | PF02991 | 0.479 |
LIG_LIR_Gen_1 | 152 | 163 | PF02991 | 0.411 |
LIG_LIR_Gen_1 | 313 | 324 | PF02991 | 0.568 |
LIG_LIR_Nem_3 | 117 | 123 | PF02991 | 0.365 |
LIG_LIR_Nem_3 | 152 | 158 | PF02991 | 0.374 |
LIG_LIR_Nem_3 | 22 | 28 | PF02991 | 0.330 |
LIG_LIR_Nem_3 | 313 | 319 | PF02991 | 0.550 |
LIG_PCNA_yPIPBox_3 | 74 | 88 | PF02747 | 0.524 |
LIG_SH2_CRK | 93 | 97 | PF00017 | 0.381 |
LIG_SH2_STAT5 | 108 | 111 | PF00017 | 0.353 |
LIG_SH2_STAT5 | 195 | 198 | PF00017 | 0.423 |
LIG_SH2_STAT5 | 31 | 34 | PF00017 | 0.399 |
LIG_SH2_STAT5 | 349 | 352 | PF00017 | 0.378 |
LIG_SH2_STAT5 | 93 | 96 | PF00017 | 0.360 |
LIG_SH3_3 | 160 | 166 | PF00018 | 0.484 |
LIG_SH3_3 | 182 | 188 | PF00018 | 0.507 |
LIG_SH3_3 | 262 | 268 | PF00018 | 0.676 |
LIG_TRAF2_1 | 125 | 128 | PF00917 | 0.480 |
LIG_WRC_WIRS_1 | 25 | 30 | PF05994 | 0.384 |
MOD_CK1_1 | 167 | 173 | PF00069 | 0.567 |
MOD_CK1_1 | 266 | 272 | PF00069 | 0.553 |
MOD_CK2_1 | 266 | 272 | PF00069 | 0.473 |
MOD_GlcNHglycan | 116 | 119 | PF01048 | 0.429 |
MOD_GlcNHglycan | 165 | 169 | PF01048 | 0.622 |
MOD_GlcNHglycan | 171 | 174 | PF01048 | 0.631 |
MOD_GlcNHglycan | 299 | 302 | PF01048 | 0.691 |
MOD_GlcNHglycan | 3 | 6 | PF01048 | 0.545 |
MOD_GlcNHglycan | 320 | 323 | PF01048 | 0.769 |
MOD_GlcNHglycan | 328 | 331 | PF01048 | 0.681 |
MOD_GlcNHglycan | 339 | 342 | PF01048 | 0.361 |
MOD_GlcNHglycan | 388 | 391 | PF01048 | 0.370 |
MOD_GSK3_1 | 167 | 174 | PF00069 | 0.709 |
MOD_GSK3_1 | 177 | 184 | PF00069 | 0.691 |
MOD_GSK3_1 | 199 | 206 | PF00069 | 0.406 |
MOD_GSK3_1 | 259 | 266 | PF00069 | 0.593 |
MOD_GSK3_1 | 283 | 290 | PF00069 | 0.503 |
MOD_GSK3_1 | 314 | 321 | PF00069 | 0.542 |
MOD_N-GLC_2 | 382 | 384 | PF02516 | 0.352 |
MOD_NEK2_1 | 1 | 6 | PF00069 | 0.550 |
MOD_NEK2_1 | 14 | 19 | PF00069 | 0.290 |
MOD_PIKK_1 | 19 | 25 | PF00454 | 0.372 |
MOD_PIKK_1 | 287 | 293 | PF00454 | 0.544 |
MOD_PIKK_1 | 54 | 60 | PF00454 | 0.490 |
MOD_PK_1 | 332 | 338 | PF00069 | 0.434 |
MOD_PKA_1 | 213 | 219 | PF00069 | 0.422 |
MOD_PKA_1 | 246 | 252 | PF00069 | 0.504 |
MOD_PKA_1 | 263 | 269 | PF00069 | 0.500 |
MOD_PKA_1 | 287 | 293 | PF00069 | 0.528 |
MOD_PKA_2 | 114 | 120 | PF00069 | 0.345 |
MOD_PKA_2 | 245 | 251 | PF00069 | 0.620 |
MOD_PKA_2 | 287 | 293 | PF00069 | 0.535 |
MOD_PKA_2 | 363 | 369 | PF00069 | 0.486 |
MOD_Plk_1 | 127 | 133 | PF00069 | 0.329 |
MOD_Plk_4 | 332 | 338 | PF00069 | 0.554 |
TRG_ENDOCYTIC_2 | 358 | 361 | PF00928 | 0.418 |
TRG_ENDOCYTIC_2 | 93 | 96 | PF00928 | 0.355 |
TRG_ER_diArg_1 | 287 | 289 | PF00400 | 0.525 |
TRG_Pf-PMV_PEXEL_1 | 213 | 218 | PF00026 | 0.558 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1I8I6 | Leptomonas seymouri | 48% | 72% |
A0A1X0P5K1 | Trypanosomatidae | 36% | 89% |
A0A3Q8IGA8 | Leishmania donovani | 71% | 100% |
A0A3S5IR12 | Trypanosoma rangeli | 35% | 92% |
A4IBG1 | Leishmania infantum | 71% | 100% |
C9ZZA3 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 32% | 75% |
E9AF75 | Leishmania major | 69% | 100% |
E9B6D1 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 72% | 100% |
V5B3S2 | Trypanosoma cruzi | 36% | 91% |